Coronha Ana Lúcia, Camilo Maria Ermelinda, Ravasco Paula
Laboratório de Nutrição/Unidade de Nutrição e Metabolismo, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Acta Med Port. 2011 Dec;24 Suppl 4:769-78. Epub 2011 Dec 31.
In the past few years, there has been a growing interest on body composition changes of cancer patients. Muscle mass and fat mass are pointed out as the most important compartments from a physiological point of view, as their changes are the ones with the most impact on disease. The excess of fat mass is related with increased risk of incidence and recurrence of some types of cancer, and some studies identify it as a major contributing factor for increased morbidity and mortality in cancer patients. Weight loss in cancer is frequent and is associated with symptoms, circulating pro-cachectic substances produced by the tumour, and/or hypermetabolism states, not compensated with adequate intake. Muscle mass depletion is the most worrying, and has been associated with decreased functional capacity, increased toxicity of anti-neoplastic treatments, longer length of stay and higher risk of nosocomial infections. In end stage disease, some patients may develop cancer cachexia, an irreversible condition highly associated with mortality. Of note that, lean body mass depletion may occur with excess fat mass (sarcopenic obesity), a condition that combines the health risks of obesity and those of sarcopenia. The high prevalence of malnutrition in cancer patients justifies its relevance. Many patients point it as a cause for the reduction of physical, cognitive, emotional and social functions, as well as anorexia, fatigue, dyspnoea, insomnia, gastrointestinal symptoms and worse Quality of Life. Additionally, body composition may be affected by nutrition, lifestyles and physical activity; therefore, any approach to the patient should include all these dimensions, with special emphasis on individualised nutritional intervention. Therefore, nutritional therapy should be adjuvant to any treatment, as it is essential in all stages of the disease: for its development, during the treatment(s) and in the follow-up period. The aim of nutritional intervention is to promote changes in body composition, by maintaining or increasing lean body mass and keeping fat mass in healthy levels, which may have a positive impact on Quality of Life, response to treatment(s), prognosis and reduced health care costs.
在过去几年中,人们对癌症患者身体成分变化的兴趣日益浓厚。从生理学角度来看,肌肉量和脂肪量被认为是最重要的组成部分,因为它们的变化对疾病影响最大。脂肪量过多与某些类型癌症的发病风险和复发风险增加有关,一些研究将其确定为癌症患者发病率和死亡率增加的主要促成因素。癌症患者体重减轻很常见,这与症状、肿瘤产生的循环促恶病质物质和/或高代谢状态有关,而这些状态无法通过充足的摄入得到补偿。肌肉量减少最为令人担忧,它与功能能力下降、抗肿瘤治疗毒性增加、住院时间延长以及医院感染风险升高有关。在疾病终末期,一些患者可能会发展为癌症恶病质,这是一种与死亡率高度相关的不可逆病症。需要注意的是,瘦体重减少可能与脂肪量过多(肌少症性肥胖)同时出现,这种情况兼具肥胖和肌少症的健康风险。癌症患者营养不良的高患病率证明了其重要性。许多患者指出,营养不良是身体、认知、情感和社交功能下降的原因,也是厌食、疲劳、呼吸困难、失眠、胃肠道症状以及生活质量下降的原因。此外,身体成分可能会受到营养、生活方式和体育活动的影响;因此,对患者的任何治疗方法都应涵盖所有这些方面,尤其要强调个体化营养干预。因此,营养治疗应作为任何治疗的辅助手段,因为它在疾病的各个阶段都至关重要:在疾病发展过程中、治疗期间以及随访期间。营养干预的目的是通过维持或增加瘦体重并将脂肪量保持在健康水平来促进身体成分的变化,这可能对生活质量、治疗反应、预后以及降低医疗成本产生积极影响。